Works matching IS 20401116 AND DT 2025 AND VI 16 AND IP 5


Results: 22
    1
    2
    3
    4
    5
    6

    Effect of administration and withdrawal of the sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single‐arm study (RESTORE‐nephropathy study)

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 5, p. 817, doi. 10.1111/jdi.70018
    By:
    • Shigeta, Ayako;
    • Tanaka, Masami;
    • Meguro, Shu;
    • Morimoto, Jiro;
    • Imai, Takatoshi;
    • Yamauchi, Akira;
    • Kanazawa, Yasuhiko;
    • Kawai, Toshihide;
    • Azuma, Koichiro;
    • Yamada, Satoru;
    • Endo, Sho;
    • Itoh, Hiroshi;
    • Hayashi, Kaori
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    miR‐92a aggravates metabolic syndrome via KLF2/miR‐483 axis.

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 5, p. 893, doi. 10.1111/jdi.14416
    By:
    • Zhao, Zhe;
    • Ma, Chaofeng;
    • Wang, Longzhi;
    • Xia, Yuhang;
    • Li, Jun;
    • Yang, Wei;
    • Pang, Juan;
    • Ding, Hui;
    • Wang, Haifeng;
    • Bai, Liang;
    • Shang, Fenqing;
    • Zhang, Feng
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Issue Information.

    Published in:
    Journal of Diabetes Investigation, 2025, v. 16, n. 5, p. 765, doi. 10.1111/jdi.14238
    Publication type:
    Article
    21
    22